# Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer

> **NCT00028730** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 25 (actual)

## Conditions studied

- Leukemia
- Lymphoma
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Neoplasms

## Interventions

- **BIOLOGICAL:** anti-thymocyte globulin
- **BIOLOGICAL:** filgrastim
- **DRUG:** cyclophosphamide
- **DRUG:** fludarabine phosphate
- **DRUG:** thiotepa
- **PROCEDURE:** allogeneic bone marrow transplantation
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00028730
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** 2006-07
- **Final completion:** 2008-06
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2015-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00028730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00028730, "Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00028730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*